$1.74
-0.08-4.40%
At close: -
$1.73
-0.01-0.57%
After Hours: Apr 17, 4:28 PM EDT
Comments
Loading...
BioXcel Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:BTAI | Benzinga
BioXcel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-3.040
Quarterly Revenue Estimate
$350.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.27M
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BTAI | BioXcel Therapeutics | -$13.92 | -$3.04 | — | — | $582.00K | $350.00K | — | — | 05/08/2025 | Get Alert |
| BTAI | BioXcel Therapeutics | -$12.16 | -$4.96 | -$3.57 | 28.02% | $376.00K | $413.84K | $366.00K | -11.56% | 03/27/2025 | Get Alert |
| BTAI | BioXcel Therapeutics | -$25.28 | -$7.68 | -$5.12 | 33.33% | $341.00K | $1.33M | $214.00K | -83.91% | 11/14/2024 | Get Alert |
| BTAI | BioXcel Therapeutics | -$29.28 | -$11.36 | -$3.36 | 70.42% | $457.00K | $680.00K | $1.10M | 62.35% | 08/06/2024 | Get Alert |
| BTAI | BioXcel Therapeutics | -$29.44 | -$11.20 | -$13.92 | -24.29% | $206.00K | $460.00K | $582.00K | 26.52% | 05/09/2024 | Get Alert |
| BTAI | BioXcel Therapeutics | -$31.20 | -$14.56 | -$12.16 | 16.48% | $238.00K | $710.00K | $376.00K | -47.04% | 03/12/2024 | Get Alert |
| BTAI | BioXcel Therapeutics | -$23.84 | -$20.96 | -$25.28 | -20.61% | $137.00K | $670.00K | $341.00K | -49.10% | 11/14/2023 | Get Alert |
| BTAI | BioXcel Therapeutics | -$21.60 | -$28.00 | -$29.28 | -4.57% | $0.00 | $450.00K | $457.00K | 1.56% | 08/14/2023 | Get Alert |
| BTAI | BioXcel Therapeutics | -$17.92 | -$25.92 | -$29.44 | -13.58% | $0.00 | $500.00K | $206.00K | -58.80% | 05/08/2023 | Get Alert |
| BTAI | BioXcel Therapeutics | -$14.88 | -$23.20 | -$31.20 | -34.48% | $0.00 | $1.25M | $238.00K | -80.96% | 03/09/2023 | Get Alert |
| BTAI | BioXcel Therapeutics | -$15.36 | -$21.60 | -$23.84 | -10.37% | $0.00 | $1.09M | $137.00K | -87.43% | 11/10/2022 | Get Alert |
| BTAI | BioXcel Therapeutics | -$17.76 | -$19.52 | -$21.60 | -10.66% | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| BTAI | BioXcel Therapeutics | -$17.28 | -$18.40 | -$17.92 | 2.61% | $0.00 | $120.00K | $0.00 | -100.00% | 05/09/2022 | Get Alert |
| BTAI | BioXcel Therapeutics | -$13.92 | -$17.60 | -$14.88 | 15.45% | $0.00 | — | $0.00 | — | 03/10/2022 | Get Alert |
| BTAI | BioXcel Therapeutics | -$17.12 | -$16.80 | -$15.36 | 8.57% | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
| BTAI | BioXcel Therapeutics | -$16.96 | -$17.28 | -$17.76 | -2.78% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
| BTAI | BioXcel Therapeutics | -$12.64 | -$15.04 | -$17.28 | -14.89% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| BTAI | BioXcel Therapeutics | -$7.20 | -$15.36 | -$13.92 | 9.38% | $0.00 | — | $0.00 | — | 03/11/2021 | Get Alert |
| BTAI | BioXcel Therapeutics | -$9.12 | -$12.80 | -$17.12 | -33.75% | $0.00 | — | $0.00 | — | 11/12/2020 | Get Alert |
| BTAI | BioXcel Therapeutics | -$8.64 | -$12.00 | -$16.96 | -41.33% | $0.00 | — | $0.00 | — | 08/14/2020 | Get Alert |
| BTAI | BioXcel Therapeutics | -$7.36 | -$9.44 | -$12.64 | -33.90% | $0.00 | — | $0.00 | — | 05/12/2020 | Get Alert |
BioXcel Therapeutics (BTAI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-3.57 | $-4.96 | 28.0 % |
| Q3 | 2024-11-14 | $-5.12 | $-7.68 | 33.3 % |
| Q2 | 2024-08-06 | $-3.36 | $-11.36 | 70.4 % |
| Q1 | 2024-05-09 | $-13.92 | $-11.20 | -24.3 % |
BioXcel Therapeutics (BTAI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $366.00K | $413.84K | -11.6 % |
| Q3 | 2024-11-14 | $214.00K | $1.33M | -83.9 % |
| Q2 | 2024-08-06 | $1.10M | $680.00K | 62.4 % |
| Q1 | 2024-05-09 | $582.00K | $460.00K | 26.5 % |
FAQ
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics (BTAI) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for BioXcel Therapeutics (NASDAQ:BTAI)?
The Actual EPS was $-3.57, which beat the estimate of $-4.96.
What were BioXcel Therapeutics’s (NASDAQ:BTAI) revenues?
The Actual Revenue was $366K, which missed the estimate of $413.8K.
Browse earnings estimates, EPS, and revenue on all stocks.
